Krsnaa Diagnostics Ltd vs Nephro Care India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 30, 2026

Key Highlights

The Latest Trading Price of Krsnaa Diagnostics Ltd is ₹ 504.1 as of 30 Oct 15:30 . The P/E Ratio of Krsnaa Diagnostics Ltd changed from 22.3 on March 2022 to 16.7 on March 2026 . This represents a CAGR of -5.62% over 5 yearsThe P/E Ratio of Nephro Care India Ltd changed from 25.4 on March 2026 to 25.4 on March 2026 . This represents a CAGR of 0.00% over 1 years The Market Cap of Krsnaa Diagnostics Ltd changed from ₹ 1524 crore on March 2022 to ₹ 1690 crore on March 2026 . This represents a CAGR of 2.09% over 5 yearsThe Market Cap of Nephro Care India Ltd changed from ₹ 85.32 crore on March 2026 to ₹ 85.32 crore on March 2026 . This represents a CAGR of 0.00% over 1 years The revenue of Krsnaa Diagnostics Ltd for the Jun '26 is ₹ 242.78 crore as compare to the Mar '26 revenue of ₹ 224.1 crore. This represent the growth of 8.34% The revenue of Nephro Care India Ltd for the Jun '26 is ₹ 29.41 crore as compare to the Mar '26 revenue of ₹ 27.58 crore. This represent the growth of 6.64% The ebitda of Krsnaa Diagnostics Ltd for the Jun '26 is ₹ 65.23 crore as compare to the Mar '26 ebitda of ₹ 86.37 crore. This represent the decline of -24.48% The ebitda of Nephro Care India Ltd for the Jun '26 is ₹ 3.84 crore as compare to the Mar '26 ebitda of ₹ 2.85 crore. This represent the growth of 34.74% The net profit of Krsnaa Diagnostics Ltd changed from ₹ 17.92 crore to ₹ 16.55 crore over 9 quarters. This represents a CAGR of -3.47% The net profit of Nephro Care India Ltd changed from ₹ -0.65 crore to ₹ 1.61 crore over 5 quarters. This represents a CAGR of NaN% The Dividend Payout of Krsnaa Diagnostics Ltd changed from 11.1 % on March 2022 to 6.32 % on March 2026 . This represents a CAGR of -10.65% over 5 yearsThe Dividend Payout of Nephro Care India Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Limited was originally incorporated as Krsna Diagnostics Private Limited' at Pune, Maharashtra dated December 22, 2010.
The Company name was changed to Krsnaa Diagnostics Private Limited', pursuant to a fresh Certificate of Incorporation issued by the RoC on January 29, 2015.
Thereafter, the status got converted into a Public Company and the name was changed to Krsnaa Diagnostics Limited pursuant to a fresh Certificate of Incorporation issued by the RoC on 06 May, 2021. The Company is primarily engaged in providing diagnostic services centres all over India.
The Company is providing Radiology and Pathology services for X-ray, CT Scan, MRI, Mammography, Bone Densitometry, Ultrasound, Colout Doppler, Tele-Reporting services, all type of blood and urine investigation and other related diagnostic services.

About Nephro Care India Ltd

Nephro Care India Limited was originally incorporated on July 08, 2014 as a Private Limited Company as 'Nephro Care India Private Limited' with the Registrar of Companies, West Bengal.
Subsequently, Company converted into a Public Limited Company and the name of Company was changed to Nephro Care India Limited' and a fresh Certificate of Incorporation dated March 5, 2024, was issued by the Registrar of Companies, Central Processing Centre. Nephro Care was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients.
The Company is a one stop treatment centre based in Kolkata that offer clinical and lifestyle solutions and services and renal insufficiency treatment to patients.
The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness.

FAQs for the comparison of Krsnaa Diagnostics Ltd and Nephro Care India Ltd

Which company has a larger market capitalization, Krsnaa Diagnostics Ltd or Nephro Care India Ltd?

Market cap of Krsnaa Diagnostics Ltd is 1,635 Cr while Market cap of Nephro Care India Ltd is 134 Cr

What are the key factors driving the stock performance of Krsnaa Diagnostics Ltd and Nephro Care India Ltd?

The stock performance of Krsnaa Diagnostics Ltd and Nephro Care India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Krsnaa Diagnostics Ltd and Nephro Care India Ltd?

As of October 30, 2026, the Krsnaa Diagnostics Ltd stock price is INR ₹504.1. On the other hand, Nephro Care India Ltd stock price is INR ₹81.3.

How do dividend payouts of Krsnaa Diagnostics Ltd and Nephro Care India Ltd compare?

To compare the dividend payouts of Krsnaa Diagnostics Ltd and Nephro Care India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.